CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 23 enrolled
Drug / intervention
Levonorgestrel-releasing intrauterine device (LNG-IUS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00653159
NCT00653159Phase 4Completed
CompareCT.gov

Intrauterine Contraception for Adolescents Aged 14 to 18: A Multi-center Randomized Controlled Feasibility Trial of Levonorgestrel-releasing Intrauterine System Compared to the Copper T 380A

University of Chicago·interventional·Posted Apr 4, 2008·Updated Feb 23, 2023

In Brief

A Phase 4 clinical trial evaluating Levonorgestrel-releasing intrauterine device (LNG-IUS) and Copper T380A intrauterine device (CuT380A) for Contraception. Completed, enrolled 23 participants across 2 sites.

Detailed Summary

This is a pilot study to determine the feasibility for a randomized controlled trial of two forms of intrauterine contraception: the Levonorgestrel intrauterine system (LNG-IUS) and the Copper T 380A.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsUniversity of Illinois at Chicago

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 4, 2008
Enrollment StartJul 1, 2007
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.2 years ago

Interventions

Levonorgestrel-releasing intrauterine device (LNG-IUS)device

Teens are randomly assigned to receive the LNG-IUS after completing a screening visit.

Copper T380A intrauterine device (CuT380A)device

Teens are randomly assigned to Copper T380 after the screening visit